250 related articles for article (PubMed ID: 2319186)
1. Activation of complement by circulating immune complexes isolated from leprosy patients.
Tyagi P; Ramanathan VD; Girdhar BK; Katoch K; Bhatia AS; Sengupta U
Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):31-8. PubMed ID: 2319186
[TBL] [Abstract][Full Text] [Related]
2. Polyethylene glycol precipitates in serum during and after erythema nodosum leprosum--study of their composition and anticomplementary activity.
Saha K; Chakrabarty AK; Sharma VK; Sehgal VN
Int J Lepr Other Mycobact Dis; 1984 Mar; 52(1):44-8. PubMed ID: 6538557
[TBL] [Abstract][Full Text] [Related]
3. Suppressive effect of circulating immune complexes from leprosy patients on the lymphocyte proliferation induced by M. leprae antigens in healthy responders.
Tyagi P; Patil SA; Girdhar BK; Katoch K; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):562-9. PubMed ID: 1299711
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of circulating immune complexes in leprosy.
Ramos GS; Bottasso OA; Morini JC; Segal-Eiras A
Rev Argent Microbiol; 1988; 20(4):163-70. PubMed ID: 3247413
[TBL] [Abstract][Full Text] [Related]
5. Solubilization of preformed immune complexes in sera of patients with type 1 and type 2 lepra reactions.
Chakrabarty AK; Kashyap A; Sehgal VN; Saha K
Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):559-65. PubMed ID: 3221112
[TBL] [Abstract][Full Text] [Related]
6. Serum immune complexes in erythema nodosum leprosum reactions of leprosy.
Rao TD; Rao PR
Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953
[TBL] [Abstract][Full Text] [Related]
7. Immunologic defects in leprosy patients. II. Interleukin 1, interleukin 2, and interferon production in leprosy patients.
Makonkawkeyoon S; Kasinrerk W; Supajatura V; Hirunpetcharat C; Vithayasai V
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):311-8. PubMed ID: 1695911
[TBL] [Abstract][Full Text] [Related]
8. Reduced complement-mediated immune complex solubilization in leprosy patients.
Ramanathan VD; Sharma P; Ramu G; Sengupta U
Clin Exp Immunol; 1985 Jun; 60(3):553-8. PubMed ID: 3874729
[TBL] [Abstract][Full Text] [Related]
9. Immunologic defects in leprosy patients. I. Evidence of immune aberration of suppressor-T lymphocytes in lepromatous leprosy.
Makonkawkeyoon S; Kasinrerk W; Dettrairat S; Vithayasai V
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):302-10. PubMed ID: 2142947
[TBL] [Abstract][Full Text] [Related]
10. The functional state of the complement system in leprosy.
Gomes GI; Nahn EP; Santos RK; Da Silva WD; Kipnis TL
Am J Trop Med Hyg; 2008 Apr; 78(4):605-10. PubMed ID: 18385356
[TBL] [Abstract][Full Text] [Related]
11. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
Kifayet A; Hussain R
Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
[TBL] [Abstract][Full Text] [Related]
12. Detection of antibodies to 35 kD determinant of M. leprae in urine and serum of leprosy patients.
Patil S; Dwivedi P; Kiran K; Singh K; Sengupta U
Acta Leprol; 1990; 7(2):139-43. PubMed ID: 1699385
[TBL] [Abstract][Full Text] [Related]
13. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
14. Circulating immune complexes in leprosy sera: demonstration of antibodies against mycobacterial glycolipidic antigens in isolated immune complexes.
Yamashita JT; Cruaud P; Papa F; Rotta O; David HL
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):44-50. PubMed ID: 8326180
[TBL] [Abstract][Full Text] [Related]
15. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
Laal S; Mishra RS; Nath I
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):481-93. PubMed ID: 2958570
[TBL] [Abstract][Full Text] [Related]
16. Is PGL-1 also present in Leishmania donovani promastigotes?
Gupta PN; Pal NK
Indian J Lepr; 1998; 70(2):161-4. PubMed ID: 9724851
[TBL] [Abstract][Full Text] [Related]
17. Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states.
George J; Bhatia VN; Balakrishnan S; Ramu G
Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):20-4. PubMed ID: 2030313
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
19. Serum lymphocytotoxic activity in leprosy.
Rasheed FN; Locniskar M; McCloskey DJ; Hasan RS; Chiang TJ; Rose P; de Soldenhoff R; Festenstein H; McAdam KP
Clin Exp Immunol; 1989 Jun; 76(3):391-7. PubMed ID: 2752595
[TBL] [Abstract][Full Text] [Related]
20. A method for the detection of M. leprae antigens in urine of leprosy patients by gel diffusion and gel electrophoretic techniques and significance in diagnosis.
Patil SA; Katoch K; Sengupta U
Acta Leprol; 1991; 7(5):403-7. PubMed ID: 1805496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
